Aidoc Expands Cardiology Solutions by Bringing Us2.ai’s Echo AI Into Proprietary Operating System

Aidoc, the leading provider of healthcare AI solutions, announced a partnership with Us2.ai to bring its FDA-cleared and CE Marked AI algorithm to analyze and interpret echocardiograms (echo) into its proprietary aiOS.

Within Aidoc’s aiOS – a first-in-market operating system that can orchestrate multiple independent AI algorithms across the native workflows of various specialties – the Us2.ai algorithm can deliver a fully automated and standardized echo report to sonographers and cardiologists.

Recommended AI News: Researchers from Gwangju Institute of Science and Technology Develop a New Method for Denoising Images

“It’s clear hospitals and health systems see significant value in orchestrating AI from a single, trusted partner. Full automation for the analysis of echocardiography brings a long overdue technology upgrade to this modality,” said Seth Koeppel, Head of Business Development for Us2.ai, “We believe this partnership with Aidoc will enhance the speed at which hospitals can realize ROI from AI solutions.”

Echocardiography is an affordable, widely used tool to diagnose heart disease. Each takes 40 to 60 minutes to complete, and the manual time-consuming process to acquire, review and then analyze the images limits the number of echos that can be performed efficiently.

Us2.ai’s algorithm automatically searches for optimal images and takes standardized measurements of the heart within minutes. Aidoc’s aiOS makes it easier for clinicians to act on both acute and chronic findings through its ecosystem of AI solutions, allowing the appropriate level of care management to be initiated.

Recommended AI News: Eko Awarded $2.7 Million SBIR Grant from NIH to Develop Pulmonary Hypertension AI

The ability to efficiently run several AI solutions on a single patient, and then distribute the AI results to the right physicians across their native workflows, is unique to Aidoc’s aiOS. By always running in the background, the aiOS can orchestrate algorithms to automatically assess each scan for multiple pathologies at the same time. Its ability to integrate with electronic health records (EHR) provides a holistic view of the patient, providing real time data to appropriate teams.

“Our partnership with Us2.ai allows our health system partners to further expand the clinical value of AI to cardiac care,” said Elad Walach, CEO at Aidoc. “Health systems cannot work with thousands of AI point solutions for each service line. Our aiOS allows health systems to think strategically about AI and build an end-to-end intelligence layer across the health system.”

The echo algorithm is a complement to Aidoc’s growing cardiovascular platform, which includes both AI and care coordination solutions for many pathologies, including pulmonary embolism, deep vein thrombosis, aortic dissection and aortic aneurysm. Since 2016, more than 50 studies have proven Aidoc’s clinical effectiveness, reliability and cost benefits across multiple performance indicators.

Recommended AI News: LZG International, Inc. (FatBrain AI) Announces Plans to Uplist to OTCQB Venture Market

[To share your insights with us, please write to sghosh@martechseries.com]